Clinical Trial Update: Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction [Phase 1]

View source ↗

Summary

Phase 1 randomized study evaluating intracoronary transplantation of bone marrow stem cells in myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Intracoronary bone marrow stem cell therapy (bone marrow stem cells)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Myocardial Infarction | Phase 1 | Status: COMPLETED